Takehito Shukuya

16PUBLICATIONS
27CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer diagnosisEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 17, 2026
Interleukin-1α-Mediated Activation of TNF-α/NF-κB Signaling Confers Resistance to Osimertinib in EGFR-Mutant Non-Small-Cell Lung Cancer.

|Jul 12, 2025
Current Status of Multimodal Therapy for Oligometastatic Disease, Induced Oligometastatic Disease, and Oligo-Progressive Disease in EGFR-Mutated Non-Small-Cell Lung Cancer.

Taichi Miyawaki, Hirotsugu Kenmotsu, Ryo Ko

|Apr 23, 2025
Chest Tube Drainage, Bone Radiotherapy, and Brain Radiotherapy in Advanced Lung Cancer: A Retrospective Analysis of Associated Factors and Survival.

Shoko Sonobe Shimamura, Takehito Shukuya, Kazuhisa Takahashi

|Oct 08, 2024
Second malignancy in advanced or recurrent non-small cell lung cancer after the advent of molecular targeted drugs and immunotherapy.

Yoshihiro Masui, Takehito Shukuya, Shunichi Kataoka

|Oct 01, 2024
Impact of Cachexia and First-Line Systemic Therapy for Previously Untreated Advanced Non-Small Cell Lung Cancer: NEJ050A.

Keita Miura, Takehito Shukuya, Naoki Furuya

|Apr 24, 2024
Lymphangioleiomyomatosis as a potent lung cancer risk factor: Insights from a Japanese large cohort study.

Masahiro Torasawa, Takehito Shukuya, Kohei Uemura

Pageof 3

Frequent Collaborators

4 joint publications

Ryo Ko

3 joint publications

Keita Miura

2 joint publications

Kazuhisa Takahashi

2 joint publications

Kana Kurokawa